Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
well as the fellowship programme at the Wallenberg Centres for Molecular Medicine (WCMM), within the Program for Academic leaders in Life Science (PALS) network; see https://www.palsnetwork.se . SciLifeLab is now seeking
-
. For more information, please see: https://www.scilifelab.se/data-driven/ddls-research-school/ The future of life science is data-driven. Will you be part of that change? Then join us in this unique program
-
Uppsala University, Disciplinary Domain of Science and Technology, Faculty of Mathematics and Computer Science, Department of Information Technology Are you interested in working with probabilistic
-
Uppsala University, Disciplinary Domain of Science and Technology, Faculty of Mathematics and Computer Science, Department of Information Technology Are you interested in working with machine
-
Are you excited about research at the intersection of genomics and data science? We are looking for a researcher to join our team and contribute to advancing our understanding of genome evolution
-
School of Engineering Sciences at KTH Project description Third-cycle subject: Biological Physics The Hannebelle Lab at the Division of Biophysics, Department of Applied Physics, studies
-
Institute (MBW) experimentally addresses fundamental problems in molecular cell biology, integrative biology, and infection and immunobiology. State-of-the art and advanced methodologies are applied in a
-
advanced technology development to biomedical studies. The main research areas include immuno-oncology, sensitization, and biomarkers. Advanced technologies are utilized within the department, including
-
composed of the following four departments: The Department of Infectious Diseases The Department of Microbiology and Immunology The Department of Medical Biochemistry and Cell Biology The Department
-
) at Uppsala University and SciLifeLab , the national infrastructure for life science. Project description Immunotherapy has become a life-saving option for advanced cancer patients. However, only a minority of